Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,039 GBX | +0.12% | +6.74% | +13.47% |
05:01pm | FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications | MT |
04:50pm | FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.47% | 234B | |
+34.25% | 664B | |
+29.51% | 567B | |
-7.13% | 354B | |
+19.57% | 330B | |
+4.21% | 286B | |
+5.28% | 199B | |
-9.94% | 196B | |
-4.59% | 148B | |
-10.52% | 145B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca : Merck & Co.'s Prostate Cancer Drug Extends Lives in Late-Stage Study